tetano
Editor, Senior Moderator
Pediatrics
. 2024 May 8:e2023065003.
doi: 10.1542/peds.2023-065003. Online ahead of print. Prescribing Patterns of Nonrecommended Medications for Children With Acute COVID-19
Julianne E Burns[SUP] 1 [/SUP], Alex Dahlen[SUP] 2 [/SUP], Laura L Bio[SUP] 3 [/SUP], Lisa J Chamberlain[SUP] 4 [/SUP], Hannah K Bassett[SUP] 5 [/SUP], Raksha Ramaraj[SUP] 2 [/SUP], Hayden T Schwenk[SUP] 1 [/SUP], Ronald J Teufel 2nd[SUP] 6 [/SUP], Alan R Schroeder[SUP] 5 [/SUP]
Affiliations
Objective: Repurposed medications for acute coronavirus disease 2019 (COVID-19) continued to be prescribed after results from rigorous studies and national guidelines discouraged use. We aimed to describe prescribing rates of nonrecommended medications for acute COVID-19 in children, associations with demographic factors, and provider type and specialty.
Methods: In this retrospective cohort of children <18 years in a large United States all-payer claims database, we identified prescriptions within 2 weeks of an acute COVID-19 diagnosis. We calculated prescription rate, performed multivariable logistic regression to identify risk factors, and described prescriber type and specialty during nonrecommended periods defined by national guidelines.
Results: We identified 3 082 626 COVID-19 diagnoses in 2 949 118 children between March 7, 2020 and December 31, 2022. Hydroxychloroquine (HCQ) and ivermectin were prescribed in 0.03% and 0.14% of COVID-19 cases, respectively, during nonrecommended periods (after September 12, 2020 for HCQ and February 5, 2021 for ivermectin) with considerable variation by state. Prescription rates were 4 times the national average in Arkansas (HCQ) and Oklahoma (ivermectin). Older age, nonpublic insurance, and emergency department or urgent care visit were associated with increased risk of either prescription. Additionally, residence in nonurban and low-income areas was associated with ivermectin prescription. General practitioners had the highest rates of prescribing.
Conclusions: Although nonrecommended medication prescription rates were low, the overall COVID-19 burden translated into high numbers of ineffective and potentially harmful prescriptions. Understanding overuse patterns can help mitigate downstream consequences of misinformation. Reaching providers and parents with clear evidence-based recommendations is crucial to children's health.
. 2024 May 8:e2023065003.
doi: 10.1542/peds.2023-065003. Online ahead of print. Prescribing Patterns of Nonrecommended Medications for Children With Acute COVID-19
Julianne E Burns[SUP] 1 [/SUP], Alex Dahlen[SUP] 2 [/SUP], Laura L Bio[SUP] 3 [/SUP], Lisa J Chamberlain[SUP] 4 [/SUP], Hannah K Bassett[SUP] 5 [/SUP], Raksha Ramaraj[SUP] 2 [/SUP], Hayden T Schwenk[SUP] 1 [/SUP], Ronald J Teufel 2nd[SUP] 6 [/SUP], Alan R Schroeder[SUP] 5 [/SUP]
Affiliations
- PMID: 38716573
- DOI: 10.1542/peds.2023-065003
Objective: Repurposed medications for acute coronavirus disease 2019 (COVID-19) continued to be prescribed after results from rigorous studies and national guidelines discouraged use. We aimed to describe prescribing rates of nonrecommended medications for acute COVID-19 in children, associations with demographic factors, and provider type and specialty.
Methods: In this retrospective cohort of children <18 years in a large United States all-payer claims database, we identified prescriptions within 2 weeks of an acute COVID-19 diagnosis. We calculated prescription rate, performed multivariable logistic regression to identify risk factors, and described prescriber type and specialty during nonrecommended periods defined by national guidelines.
Results: We identified 3 082 626 COVID-19 diagnoses in 2 949 118 children between March 7, 2020 and December 31, 2022. Hydroxychloroquine (HCQ) and ivermectin were prescribed in 0.03% and 0.14% of COVID-19 cases, respectively, during nonrecommended periods (after September 12, 2020 for HCQ and February 5, 2021 for ivermectin) with considerable variation by state. Prescription rates were 4 times the national average in Arkansas (HCQ) and Oklahoma (ivermectin). Older age, nonpublic insurance, and emergency department or urgent care visit were associated with increased risk of either prescription. Additionally, residence in nonurban and low-income areas was associated with ivermectin prescription. General practitioners had the highest rates of prescribing.
Conclusions: Although nonrecommended medication prescription rates were low, the overall COVID-19 burden translated into high numbers of ineffective and potentially harmful prescriptions. Understanding overuse patterns can help mitigate downstream consequences of misinformation. Reaching providers and parents with clear evidence-based recommendations is crucial to children's health.